Taiwan FDA registration ddd0aaf454f74019380a1f4b6685a25a

BD Gram-Negative Drug Susceptibility Panel - Cephalenes

TW: BD 革蘭氏陰性菌藥物敏感性試劑組 - 頭孢烯類

Taiwan·Risk Class 2·BECTON DICKINSON AND COMPANY·Registered Mar 21, 2024 – Mar 21, 2029Active

Registration details

Analysis ID: ddd0aaf454f74019380a1f4b6685a25a
Customs Code: DHA05603707103

Company information

Manufacturer: BECTON DICKINSON AND COMPANY
Manufacturer Country: United States
Authorized Representative: BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE)

Product details

Intended Use: This product contains selective antimicrobials (listed in Table 1) for drug tolerance testing against most gram-negative aerobic and facultative anaerobes, and must be used with the Phoenix Automated Microbiological System instrument.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.1645 Automatic Antibiotic Sensitivity Test System for Short Incubation Period
Import Information: Input;; QMS/QSD

Dates and status

Registration Date: Mar 21, 2024
Expiry Date: Mar 21, 2029

About this record

Access comprehensive regulatory information for BD Gram-Negative Drug Susceptibility Panel - Cephalenes in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ddd0aaf454f74019380a1f4b6685a25a and manufactured by BECTON DICKINSON AND COMPANY. The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.